Old Web
English
Sign In
Acemap
>
authorDetail
>
Philip H. Poortmans
Philip H. Poortmans
Medicine
Cancer
Pathology
Combined modality treatment
Papillary Serous Carcinoma
3
Papers
54
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Prostatın Küçük Hücreli (Nöroendokrin) Karsinomu: Nadir Kanser Ağından 30 Hastanın Etiyolojisi, Tanısı, Prognozu ve Terapötik Sonuçları-A Retrospektif Çalışması
2008
Moshe Stein
Zvi Bernstein
Ufuç Abacıoğlu
Meriç Şengöz
Robert C. Miller
Amichai Meirovitz
Abadou Zouhair
Salvador Villà Freixa
Philip H. Poortmans
Robert Kül
İbrahim Kuten
Show All
Source
Cite
Save
Citations (0)
Small Cell (Neuroendocrine) Carcinoma of the Prostate: Etiology, Diagnosis, Prognosis, and Therapeutic Implications¯ : A Retrospective Study of 30 Patients From the Rare Cancer Network
2008
The American Journal of the Medical Sciences
Moshe E. Stein
Abraham Kuten
Zvi Bernstein
Ufuç Abacıoğlu
M. Sengoz
Robert C. Miller
Amichai Meirovitz
Abadou Zouhair
Salvador Villà Freixa
Philip H. Poortmans
Robert Ash
Show All
Source
Cite
Save
Citations (54)
Outcome after combined modality treatment for uterine papillary serous carcinoma (UPSC): A Rare Cancer Network (RCN) Multicenter Study
2005
Journal of Clinical Oncology
Hadassah Goldberg
R. Abdah-Bortniak
M Shteiner
Y. Gilboa
S Villà Freixa
S Marín
A Mendez
D. Azria
Philip H. Poortmans
Abraham Kuten
Show All
Source
Cite
Save
Citations (0)
1